Results 1 to 10 of about 530,471 (260)
The purinergic receptor P2X7 as a modulator of viral vector-mediated antigen cross-presentation [PDF]
IntroductionModified Vaccinia Virus Ankara (MVA) is a safe vaccine vector inducing long- lasting and potent immune responses. MVA-mediated CD8+T cell responses are optimally induced, if both, direct- and cross-presentation of viral or recombinant ...
Ylenia Longo +13 more
doaj +2 more sources
Cross-presentation of cell-associated antigens by MHC class I in dendritic cell subsets
Dendritic cells have the unique ability to pick up dead cells carrying antigens in tissue and migrate to the lymph nodes where they can cross-present cell-associated antigens by MHC class I to CD8+ T cells. There is strong in vivo evidence that the mouse
Enric eGutiérrez-Martínez +9 more
doaj +3 more sources
STxB as an Antigen Delivery Tool for Mucosal Vaccination
Immunotherapy against cancer and infectious disease holds the promise of high efficacy with minor side effects. Mucosal vaccines to protect against tumors or infections disease agents that affect the upper airways or the lung are still lacking, however ...
Eric Tartour, Ludger Johannes
doaj +1 more source
Endo-lysosomal assembly variations among human leukocyte antigen class I (HLA class I) allotypes
The extreme polymorphisms of human leukocyte antigen class I (HLA class I) proteins enable the presentation of diverse peptides to cytotoxic T lymphocytes.
Eli Olson +2 more
doaj +1 more source
Major histocompatibility complex (MHC) class I and II are crucial for the adaptive immune system because they are involved in peptide presentation to T cells.
Synne Arstad Bjørnestad +5 more
doaj +1 more source
Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
Peptide-based cancer vaccines rely upon the strong activation of the adaptive immune response to elicit its effector function. They have shown to be highly specific and safe, but have yet to prove themselves as an efficacious treatment for cancer in the ...
Alexander J. Stephens +3 more
doaj +1 more source
IntroductionIn immunocompromised patients, Epstein-Barr virus (EBV) infection or reactivation is associated with increased morbidity and mortality, including the development of B-cell lymphomas.
Sabine Tischer-Zimmermann +11 more
doaj +1 more source
Recent Advances in Nanotechnology for Dendritic Cell-Based Immunotherapy
Dendritic cells (DCs) are the most important antigen-presenting cells that determine cancer immune responses by regulating immune activation and tolerance, especially in the initiation stage of specific responses.
Chen Qian, Li-Jun Yang, Hong Cui
doaj +1 more source
During cross-presentation, exogenous antigens (i.e. intracellular pathogens or tumor cells) are internalized and processed within the endocytic system and also by the proteasome in the cytosol.
Diego Del Balzo +3 more
doaj +1 more source
Conventional vaccines are very efficient in the prevention of bacterial infections caused by extracellular pathogens due to effective stimulation of pathogen-specific antibodies.
Ying Waeckerle-Men +13 more
doaj +1 more source

